| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9068aa2001d07c3bea38a89d11626cea |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-77
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-622
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-7051
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2863
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 |
| filingDate |
2020-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1bc2277485096135423c43c51888168b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e3f9dbc6ef2f9bdb5cdc2b21fd46633
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52080cb8795c47fb6b97be4a36caff56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_494faa07ac22b67e9cd2dd967dcf756a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aacc8055bf1cc034703517927ae037c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_00af20eb27d342fee68c7fc449eca11f |
| publicationDate |
2022-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-115348972-A |
| titleOfInvention |
Antibodies targeting FLT3 and uses thereof |
| abstract |
Disclosed herein are proteins having antibody heavy and light chain variable domains that can pair to form an antigen binding site targeting FLT3 on cells; pharmaceutical compositions comprising these proteins; and uses of these proteins and pharmaceutical compositions in methods of treatment, including for the treatment of cancer. |
| priorityDate |
2019-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |